CINQAIR: New Drug Trials Snapshot Posted

A new DRUG TRIALS SNAPSHOT FOR CINQAIR is now available.

CINQAIR is a drug for the treatment of specific type of severe asthma (called eosinophilic phenotype asthma) in adults whose asthma is not well controlled with current medications. CINQUAR is to be used in addition to asthma maintenance medications.

Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.